This Is Why Marijuana Stocks Will Run If Cannabis Is Rescheduled
Marijuana stock investors are back waiting for another rise in trading. These last few weeks have been a window of upward trading and stronger momentum. Not only did this show the possibilities of stronger trading in the future, but it also restored investors’ confidence. For a long while, the cannabis sector has been on a consistent downtrend due to the politics around reform. Now that Donald Trump has voiced his concerns about federal reform for cannabis, most marijuana stocks have seen better trading.
It has been the only time over the last 6-12 months where a bounce lasted longer than a few minutes. A big part of the sector was able to trade up with consistent momentum most of the 2nd week of August. Currently, this shows investors and those looking to find the best marijuana stocks to buy that a potential profit can be made. A potential reclassification from Schedule I to III could deliver substantial tax relief and ease banking access, potentially catalyzing institutional investment and consolidation.
If trading momentum improves, marijuana stocks may rebound even more than they have. At this time, people are creating trading plans to help improve the odds of making money with top cannabis stocks. Below are some top cannabis stocks to watch if you are looking to enter the cannabis space as an investor in 2025.
Top Marijuana Stocks For Investors 2025
- Planet 13 Holdings Inc.(OTC:PLNH)
- FLUENT Corp.(OTC:CNTMF)
- Cresco Labs Inc.(OTC:CRLBF)
Planet 13 Holdings Inc.
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. 
Q2 2025 Financial Highlights
- Revenue was $26.9 million as compared to $31.1 million, a decrease of 13.6%.
- Gross profit was $11.7 million or 43.4% as compared to $15.8 million or 50.9%.
- Total expenses were $18.5 million as compared to $19.4 million, a decrease of 4.6%.
- Net loss of $13.3 million as compared to a net loss of $8.1 million.
- Adjusted EBITDA loss of $2.4 million as compared to Adjusted EBITDA of $3.2 million.
FLUENT Corp.
FLUENT Corp., through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. 
In recent news, the company announced an exclusive partnership with Connected cannabis. Which will have a new facility to work in in Buffalo, New York. This facility doubles FLUENT’s New York cultivation capacity and further strengthens its premium wholesale portfolio across the state.
Words From The Company
“Our mission is to cultivate exceptional cannabis that reflects the highest standards of quality and consistency,” said David Vautrin, Interim CEO of FLUENT. “With this new facility, we are pairing cutting-edge technology with Connected’s master grower expertise to unlock the full potential of their genetics.”
[Read More] The Best Marijuana Stocks Before Federal Reform Is Passed
Cresco Labs Inc.
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. On August 13th, the company announced the closing of its previously announced refinancing of the Company’s senior secured credit facility. The new US$325 million senior secured term loan bears an interest rate of 12.5% per annum and matures on August 13, 2030. 
[Read More] Top Cannabis REITs to Watch This Week for Strong Dividend Income
Words From The CEO Of Cresco Labs
“This transaction is another milestone in our disciplined approach to capital management,” said Charlie Bachtell, CEO of Cresco Labs. “We have strengthened our balance sheet and removed near-term refinancing risk. With this foundation in place, we can remain focused on executing our growth strategy.”
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
